6. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their
recurrence. New Engl J Med 2017;376:2367-75.
27. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR,
Smith DG. A prospective study of risk factors for diabetic foot ulcer.
The Seattle Diabetic Foot Study. Diabetes Care 1999;22:1036-42.
28. Zhang Y, Lazzarini PA, McPhail SM, van Netten JJ, Armstrong DG,
Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care 2020;43:
964-74.
29. Stoberock K, Kaschwich M, Nicolay SS, Mahmoud N, Heidemann F,
Rie√ü HC, et al. The interrelationship between diabetes mellitus and
peripheral arterial disease. Vasa 2021;50:323-30.
30. Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K,
et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007;50:18-25.
31. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial
disease in diabetic and nondiabetic patients: a comparison of
severity and outcome. Diabetes Care 2001;24:1433-7.
32. Golledge J. Update on the pathophysiology and medical treatment
of peripheral artery disease. Nat Rev Cardiol 2022;19:456-74.
33. Low Wang CC, Blomster JI, Heizer G, Berger JS, Baumgartner I,
Fowkes FGR, et al. Cardiovascular and limb outcomes in patients
with diabetes and peripheral artery disease: the EUCLID Trial. J Am
Coll Cardiol